Ambu Inc. Ambu aView 2 A Monitor-The Ambu aView 2 Advance is intended to display live imaging data from compatible Ambu visualization devices, portable endoscopy system. Catalog No: 405011000 Recall
Hazard assessment based on recall description.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Ambu aView 2 A Monitor-The Ambu aView 2 Advance is intended to display live imaging data from compatible Ambu visualization devices, portable endoscopy system. Catalog No: 405011000
Brand
Ambu Inc.
Lot Codes / Batch Numbers
UDI: 5707480145089 Version no.: 054 thru 056, 058 thru 059 Product manufactured prior to Oct 29, 2020
Products Sold
UDI: 5707480145089 Version no.: 054 thru 056; 058 thru 059 Product manufactured prior to Oct 29, 2020
Ambu Inc. is recalling Ambu aView 2 A Monitor-The Ambu aView 2 Advance is intended to display live imaging data from compat due to Multiple impacts, for example from being dropped, can cause to the Ambu aView 2 Advance to short-circuit and under special circumstances make the lith. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Multiple impacts, for example from being dropped, can cause to the Ambu aView 2 Advance to short-circuit and under special circumstances make the lithium-ion battery in the device combust leading to smoke and flames
Recommended Action
Per FDA guidance
Ambu Inc. (US Distirbutor) issued Urgent Field Safety Notice Instruction for Use update for aView 2 Advance on July 21, 2023 delivered via sales representative. Letter states reason for recall, health risk and action to take: The information in this Field Safety Notice is therefore only related to the earliest configurations (versions) of Ambu aView" 2 Advance as listed above. Please communicate this information to relevant personnel within your organization. Included with the Field Safety Notice, you will find an insert for the Instruction for Use for Ambu aView" 2 Advance. The insert should be read and kept together with Instruction for Use you received together with your Ambu aView" 2 Advance. The information is also included in Appendix 2 of this notice. Ambu A/S is not removing any Ambu aView 2" Advance from the field; devices remain available for use. Within one month of receipt of this letter, please return confirmation of receipt of this Field Safety Notice (appendix 1). The traceability system at Ambu indicates that your institution has purchased an Ambu aView" 2 Advance within the affected configurations. You should check the version number and manufacturing date (as indicated above) of your device to identify if you have a potentially affected device within your facility. In the case that your device is related to the earliest configurations of Ambu aView" 2 Advance, you address this by familiarizing yourself with the information in the Instruction for Use insert and keep the insert together with the Instruction for Use. This notice needs to be passed on to all those who this might concern within your organization or to any organization where the devices could have been transferred. Please transfer this notice to other organizations on which this action has an impact. Please maintain awareness on this notice and resulting action for an appropriate period to ensure effectiveness of the corrective action. Patient safety remains our highest priority.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026